Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last A$0.47 AUD
Change Today -0.025 / -5.05%
Volume 164.3K
ELX On Other Exchanges
As of 12:58 AM 10/7/15 All times are local (Market data is delayed by at least 15 minutes).

ellex medical lasers ltd (ELX) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/2/15 - A$0.56
52 Week Low
12/18/14 - A$0.23
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ELLEX MEDICAL LASERS LTD (ELX)

Related News

No related news articles were found.

ellex medical lasers ltd (ELX) Related Businessweek News

No Related Businessweek News Found

ellex medical lasers ltd (ELX) Details

Ellex Medical Lasers Limited designs, manufactures, distributes, and sells lasers and ultrasound systems for ophthalmologists to diagnose and treat eye diseases. It offers selective laser trabeculoplasty (SLT)/YAG combination laser systems for the SLT and YAG treatment in glaucoma patients under the Tango and Solo names; iTRACK 250 microcatheter for the treatment of open-angle glaucoma; and Ultra Q Reflex, a multi-modality YAG laser with IOLs peripheral iridotomy for glaucoma, and laser vitreolysis for the treatment of floaters. The company also provides capsulotomy Ultra Q Reflex multi-modality YAG laser for the treatment of vitreous strands and opacities; and Ultra Q, a microsurgical YAG laser for IOL-friendly photodisruption. In addition, it offers photocoagulators, including Solitaire, a portable green laser for the treatment of retinal disease; Integre Pro Scan, a multi-color photocoagulation for the treatment in the macular area; and Integre Pro, a laser for use in the diagnosis and treatment of retinal disease. Further, the company provides Eye Cubed, a diagnostic ultrasound system for the posterior and anterior segments of an eye. Additionally, it offers a Retinal Rejuvenation Therapy, a non-thermal laser therapy for the treatment of age-related macular degeneration and clinically significant macular edema. The company also provides third-party medical devices and technologies. It market and sells its products directly to end-user customers, as well as through independent third-party distributors in Australia, the United States, Europe, the Middle East, Japan, Asia, South America, and internationally. Ellex Medical Lasers Limited is headquartered in Adelaide, Australia.

224 Employees
Last Reported Date: 09/29/15

ellex medical lasers ltd (ELX) Top Compensated Officers

Group Chief Executive Officer
Total Annual Compensation: A$269.1K
Founder, Executive Chairman, Technical Direct...
Total Annual Compensation: A$135.0K
Vice President of Adavnced Research
Total Annual Compensation: A$180.9K
Compensation as of Fiscal Year 2015.

ellex medical lasers ltd (ELX) Key Developments

Ellex Medical Lasers Limited Reports Unaudited Consolidated Earnings Results for the Full Year Ended June 30, 2015

Ellex Medical Lasers Limited reported unaudited consolidated earnings results for the full year ended June 30, 2015. For the year, revenue was AUD 62,679,000 against AUD 54,378,000 a year ago. Profit from before income tax was AUD 2,631,000 against AUD 1,311,000 a year ago. Profit attributable to members of the parent was AUD 1,680,000 against AUD 788,000 a year ago. Diluted earnings per share were 1.56 cents against 0.73 cents a year ago. Net cash provided by operating activities was AUD 6,324,000 against AUD 2,704,000 a year ago. Payment for property, plant and equipment was AUD 1,485,000 against AUD 1,017,000 a year ago. Payment for intangible assets was AUD 282,000 against AUD 80,000 a year ago.

Ellex Medical Lasers Limited Reports Earnings Results for the Six Months Ended December 31, 2014; Provides Earnings Guidance for the Full Year of 2015

Ellex Medical Lasers Limited reported earnings results for the six months ended December 31, 2014. For the six months, the company reported total revenue of AUD 31,244,000 against AUD 25,465,000 a year ago. EBITDA was AUD 2,703,000 against AUD 1,403,000 a year ago. PBT was AUD 1,293,000 against AUD 654,000 a year ago. Earnings per share were 0.75 cents against 0.36 cents a year ago. Net Debt as at December 31, 2014 was AUD 2.5 million. Total sales were AUD 30.7 million against AUD 25.9 million a year ago. Net Cash Flow was AUD 1.1 million against AUD 3.4 million a year ago. Operating Cash Flows was AUD 2.6 million against AUD 1.3 million a year ago. Reported NPAT was AUD 0.8 million against AUD 0.4 million a year ago. The company expects that full year revenue and profit before tax will materially exceed the prior year.

Ellex Medical Lasers Limited Provides Earnings Guidance for the Six Months Ended December 31, 2014

Ellex Medical Lasers Limited provided earnings guidance for the six months ended December 31, 2014. For the period, the company expected to report an operating profit of about $1.3 million. The result will be a material increase from $654,000 reported for the December 2013 half-year. Group revenue is expected to be $31 million, a $5 million or 19% increase compared with the prior corresponding period. The increase in revenue is primarily attributable to strong sales globally of the company's new Ultra Q Reflex laser, which is for the treatment of vitreous floaters, initial sales of the new Integre Pro retinal laser, the lower value of the Australian dollar against the US dollar, the acquisition of the Canaloplasty glaucoma surgery business and generally increased sales demand in Australia and Asia.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ELX:AU A$0.47 AUD -0.025

ELX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Glaukos Corp $21.43 USD +1.00
IRIDEX Corp $7.83 USD +0.09
Quantel €2.80 EUR +0.11
STAAR Surgical Co $8.40 USD +0.28
Synergetics USA Inc $6.69 USD +0.03
View Industry Companies

Industry Analysis


Industry Average

Valuation ELX Industry Range
Price/Earnings 29.1x
Price/Sales 0.8x
Price/Book 1.2x
Price/Cash Flow 11.6x
TEV/Sales 0.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELLEX MEDICAL LASERS LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at